A carregar...
Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus
Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance and β-cell dysfunction. Among available oral antidiabetic agents, only the thiazolidinediones (TZDs) primarily target insulin resistance. TZDs improve insulin sensitivity by activating peroxisome proliferator-activated receptor γ...
Na minha lista:
| Publicado no: | Diabetes Metab J |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Korean Diabetes Association
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8164939/ https://ncbi.nlm.nih.gov/pubmed/33866775 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2020.0272 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|